Glasgow, Scotland, November 19, 2018 Rafina Innovations Inc. (formerly HCi Viocare) (OTCQB:VICA) , provides update on recent management changes. Rafina Innovations Inc. was created to be a dynamic technology start-up. Our strength lies in our exceptional sensor-technologies and the team behind them. Rafina Innovations Inc. has created the first... more
Glasgow, Scotland, Thursday July 12, 2018. HCi Viocare (OTCQB:VICA) , is pleased to announce that, further to our Current Report on Form 8-K filed June 15, 2018, HCi Viocare has completed a name change effective July 9, 2018 to Rafina Innovations Inc. Concurrently, the Company completed a reverse split on the basis of 20:1. The Company will trade... more
Glasgow, Scotland, Wednesday, January 31 st , 2018. HCi Viocare (OTCQB:VICA) , is pleased to announce that its management, acknowledging the tremendous advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. Furthermore,... more
GLASGOW, SCOTLAND--(Marketwired - Oct 9, 2017) - HCi Viocare ("the Company" ( OTCQB : VICA )) is delighted to welcome Dr. John Doupis, MD, PhD to its team. Dr. Doupis joins the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center,... more